Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1976 1
1982 1
1983 3
1984 3
1985 2
1986 2
1987 4
1988 2
1989 9
1990 3
1991 6
1992 7
1993 13
1994 18
1995 8
1996 15
1997 13
1998 9
1999 16
2000 15
2001 13
2002 14
2003 19
2004 10
2005 15
2006 9
2007 11
2008 12
2009 16
2010 9
2011 14
2012 15
2013 13
2014 13
2015 7
2016 5
2017 3
2018 4
2019 3
2020 2
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

338 results
Results by year
Filters applied: . Clear all
Page 1
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.
Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, Lee W, Yuan J, Wong P, Ho TS, Miller ML, Rekhtman N, Moreira AL, Ibrahim F, Bruggeman C, Gasmi B, Zappasodi R, Maeda Y, Sander C, Garon EB, Merghoub T, Wolchok JD, Schumacher TN, Chan TA. Rizvi NA, et al. Among authors: bruggeman c. Science. 2015 Apr 3;348(6230):124-8. doi: 10.1126/science.aaa1348. Epub 2015 Mar 12. Science. 2015. PMID: 25765070 Free PMC article.
Genetic basis for clinical response to CTLA-4 blockade in melanoma.
Snyder A, Makarov V, Merghoub T, Yuan J, Zaretsky JM, Desrichard A, Walsh LA, Postow MA, Wong P, Ho TS, Hollmann TJ, Bruggeman C, Kannan K, Li Y, Elipenahli C, Liu C, Harbison CT, Wang L, Ribas A, Wolchok JD, Chan TA. Snyder A, et al. Among authors: bruggeman c. N Engl J Med. 2014 Dec 4;371(23):2189-2199. doi: 10.1056/NEJMoa1406498. Epub 2014 Nov 19. N Engl J Med. 2014. PMID: 25409260 Free PMC article.
Selective Serotonin Reuptake Inhibitor Toxicity.
Bruggeman C, O'Day CS. Bruggeman C, et al. 2022 Jul 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. 2022 Jul 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 30521236 Free Books & Documents.
IgG Glyco-Engineering to Improve IVIg Potency.
Bruggeman CW, Dekkers G, Visser R, Goes NWM, van den Berg TK, Rispens T, Vidarsson G, Kuijpers TW. Bruggeman CW, et al. Front Immunol. 2018 Oct 23;9:2442. doi: 10.3389/fimmu.2018.02442. eCollection 2018. Front Immunol. 2018. PMID: 30405631 Free PMC article.
Cytomegalovirus and atherogenesis.
Bruggeman CA, Marjorie HJ, Nelissen-Vrancken G. Bruggeman CA, et al. Antiviral Res. 1999 Oct;43(3):135-44. doi: 10.1016/s0166-3542(99)00051-0. Antiviral Res. 1999. PMID: 10551372 Review. No abstract available.
Developments for improved diagnosis of bacterial bloodstream infections.
Loonen AJ, Wolffs PF, Bruggeman CA, van den Brule AJ. Loonen AJ, et al. Among authors: bruggeman ca. Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1687-702. doi: 10.1007/s10096-014-2153-4. Epub 2014 May 22. Eur J Clin Microbiol Infect Dis. 2014. PMID: 24848132 Review.
Surgical site infections: how high are the costs?
Broex EC, van Asselt AD, Bruggeman CA, van Tiel FH. Broex EC, et al. Among authors: bruggeman ca. J Hosp Infect. 2009 Jul;72(3):193-201. doi: 10.1016/j.jhin.2009.03.020. Epub 2009 May 31. J Hosp Infect. 2009. PMID: 19482375 Review.
Chemokines and chemokine receptors encoded by cytomegaloviruses.
Beisser PS, Lavreysen H, Bruggeman CA, Vink C. Beisser PS, et al. Among authors: bruggeman ca. Curr Top Microbiol Immunol. 2008;325:221-42. doi: 10.1007/978-3-540-77349-8_13. Curr Top Microbiol Immunol. 2008. PMID: 18637509 Review.
Cytomegalovirus infection and vessel wall pathology.
Vossen RC, van Dam-Mieras MC, Bruggeman CA. Vossen RC, et al. Among authors: bruggeman ca. Intervirology. 1996;39(3):213-21. doi: 10.1159/000150497. Intervirology. 1996. PMID: 9058174 Review.
338 results